To mark this special occasion, some of the country’s most respected health experts from various specialties come together to ...

A new UK study has found that women working permanent night shifts face a significantly higher risk of moderate to severe ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Chronic pain, sexual dysfunction and incontinence can all stem from problems with your pelvic floor — and many men don’t even ...

WE’RE all aware that chest pain is a common sign that something’s wrong with our heart. But it’s far from the only signal, ...

A lupus diagnosis can profoundly affect many aspects of a man’s life, from sense of identity and mental health to the way one ...

“This research shows that people with COPD seem to gather a lot more carbon in their lung cells. These cells also look and ...

GSK just hit one of its main objectives for 2025 after getting FDA approval of anti-IL-5 antibody Nucala as a treatment for chronic obstructive pulmonary disease (COPD). Nucala (mepolizumab) has ...

GSK has said new data leads it to believe Nucala will be "highly competitive" with rival biologic Dupixent in COPD if it gets approved by the FDA.